Skip to main content
. Author manuscript; available in PMC: 2015 Mar 12.
Published in final edited form as: JAMA. 2014 Mar 12;311(10):1035–1045. doi: 10.1001/jama.2014.1717

Table 3.

Agreement Between Human Gene Mutation Database and Multidisciplinary Genomics Team Classification for 574 Unique, Previously Described, Inherited Disease Risk Candidates Found in 12 Participants by Whole-Genome Sequencing

HGMD Genomics Teama No. (%) of Total Variants for Each HGMD Classification Total
Disease-Causing Mutation Likely Disease Causing Mutation Disease Associated Functional Polymorphism Disease Associated Polymorphism Functional Polymorphism Frame Shift or Truncating Variantb
Not associated with an inherited disease 1 (1.4) 44 (67.8) 111 (84.1) 176 (75.9) 64 (88.9) 0 396
Likely benign, strong evidence 1 (1.4) 0 5 (3.8) 19 (8.2) 1 (1.4) 5 (100.0) 31
Some evidence suggesting benign 17 (25.0) 10 (15.4) 4 (3.0) 17 (7.3) 3 (4.2) 0 51
Uncertain significance 29 (42.6) 9 (13.8) 8 (6.1) 17 (7.3) 1 (1.4) 0 64
Some evidence suggesting pathogenic 4 (5.9) 1 (1.5) 2 (1.5) 2 (0.9) 3 (4.2) 0 12
Likely pathogenic 8 (11.8) 0 0 1 (0.4) 0 0 9
Very likely pathogenic 8 (11.8) 1 (1.5) 2 (1.5) 0 0 0 11
Total 68 65 132 232 72 5 574

Abbreviations: HGMD, Human Gene Mutation Database.

a

All variants cataloged in HGMD are, by definition, previously reported. Thus, the categories from Table S1 (in the Supplement) “Novel, predicted benign,” “Novel, predicted damaging by one program”, and “Novel, predicted damaging by two or more programs” do not apply and are not displayed.

b

Polymorphic or rare variant reported in the literature (eg, detected in the process of whole-genome/exome screening) that is predicted to truncate or otherwise alter the gene product but with no disease association reported as yet.